
TuHURA Biosciences fell 25.5% from $1.88 to $1.40, behind the S&P 500's +10.0%. Its worst day was Dec 9 (−40.9%), and its low came Feb 5 at $0.44.
Nov 17, 2025 – Nov 17, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
TuHURA Biosciences shares fell 40.9%, while the S&P 500 fell 0.1%.
−40.9%, the year's worst day · S&P 500 −0.1%
TuHURA Biosciences closed at its lowest level of the year, 76.6% below where the year started.
Story events cover the past 12 months · Times ET
−5.1% · S&P 500 −1.2%
EPS of $-0.13 beat the $-0.13 estimate on $0.00 revenue.
−9.5% · S&P 500 +0.8%
TuHURA Biosciences closed at its highest level of the year, 67.6% above where the year started.
+9.8% · S&P 500 +1.2%
EPS of $-0.13 missed the $-0.11 estimate on $0.00 revenue.
+10.4% · S&P 500 −0.1%
EPS of $-0.14 beat the $-0.15 estimate on $0.00 revenue.
+7.4% · S&P 500 −0.2%
EPS of $-0.10 beat the $-0.13 estimate on $0.00 revenue.
−4.1% · S&P 500 −0.4%
Where it ended: a close of $1.40 on Nov 17, 2026.
Nothing in the past 12 months.
All HURA dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for HURA and SPY from Benzinga historical bars. Not investment advice.